176 related articles for article (PubMed ID: 37776538)
1. CENPN suppresses autophagy and increases paclitaxel resistance in nasopharyngeal carcinoma cells by inhibiting the CREB-VAMP8 signaling axis.
Wang BR; Han JB; Jiang Y; Xu S; Yang R; Kong YG; Tao ZZ; Hua QQ; Zou Y; Chen SM
Autophagy; 2024 Feb; 20(2):329-348. PubMed ID: 37776538
[TBL] [Abstract][Full Text] [Related]
2.
Zhu Q; Zhang Q; Gu M; Zhang K; Xia T; Zhang S; Chen W; Yin H; Yao H; Fan Y; Pan S; Xie H; Liu H; Cheng T; Zhang P; Zhang T; You B; You Y
Autophagy; 2021 Jul; 17(7):1667-1683. PubMed ID: 32627648
[TBL] [Abstract][Full Text] [Related]
3. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
[TBL] [Abstract][Full Text] [Related]
4. [Autophagy promotes recurrence of nasopharyngeal carcinoma via inducing the formation of dormant polyploid giant cancer cells].
Xia T; Ji Y; Lu YN; Xie HJ; You YW; You B
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Sep; 57(9):1102-1109. PubMed ID: 36177565
[No Abstract] [Full Text] [Related]
5. MicroRNA-185 inhibits cell proliferation while promoting apoptosis and autophagy through negative regulation of TGF-β1/mTOR axis and HOXC6 in nasopharyngeal carcinoma.
Cheng JZ; Chen JJ; Wang ZG; Yu D
Cancer Biomark; 2018; 23(1):107-123. PubMed ID: 29991129
[TBL] [Abstract][Full Text] [Related]
6. Homeodomain protein DLX4 facilitates nasopharyngeal carcinoma progression via up-regulation of YB-1.
Ling Z; Long X; Li J; Feng M
Genes Cells; 2020 Jul; 25(7):466-474. PubMed ID: 32281175
[TBL] [Abstract][Full Text] [Related]
7. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.
Liu Y; Li X; Zhang Y; Tang Y; Fang W; Liu X; Liu Z
Biomed Pharmacother; 2021 Nov; 143():112096. PubMed ID: 34563951
[TBL] [Abstract][Full Text] [Related]
8. Parkin enhances sensitivity of paclitaxel to nasopharyngeal carcinoma by activating BNIP3/NIX-mediated mitochondrial autophagy.
Ni H; Liu R; Zhou Z; Jiang B; Wang B
Chin J Physiol; 2023; 66(6):503-515. PubMed ID: 38149563
[TBL] [Abstract][Full Text] [Related]
9. Timosaponin AIII Suppresses RAP1 Signaling Pathway to Enhance the Inhibitory Effect of Paclitaxel on Nasopharyngeal Carcinoma.
Li X; Lu W; Zhou T; Zhao F; Yang L
Comput Math Methods Med; 2022; 2022():6756676. PubMed ID: 35586672
[TBL] [Abstract][Full Text] [Related]
10. Acylglycerol kinase promotes paclitaxel resistance in nasopharyngeal carcinoma cells by regulating FOXM1 via the JAK2/STAT3 pathway.
Zhao C; Chen HY; Zhao F; Feng HJ; Su JP
Cytokine; 2021 Dec; 148():155595. PubMed ID: 34116927
[TBL] [Abstract][Full Text] [Related]
11. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling.
Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J
Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432
[TBL] [Abstract][Full Text] [Related]
12. Silencing long non-coding RNA H19 combined with paclitaxel inhibits nasopharyngeal carcinoma progression.
Zhu H
Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110249. PubMed ID: 32736275
[TBL] [Abstract][Full Text] [Related]
13. The IRF2/CENP-N/AKT signaling axis promotes proliferation, cell cycling and apoptosis resistance in nasopharyngeal carcinoma cells by increasing aerobic glycolysis.
Qi CL; Huang ML; Zou Y; Yang R; Jiang Y; Sheng JF; Kong YG; Tao ZZ; Feng HY; Hua QQ; Bu LH; Chen SM
J Exp Clin Cancer Res; 2021 Dec; 40(1):390. PubMed ID: 34893086
[TBL] [Abstract][Full Text] [Related]
14. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
15. m 6 A reader IGF2BP1 reduces the sensitivity of nasopharyngeal carcinoma cells to Taxol by upregulation of AKT2.
Zhao C; Zhang F; Tian Y; Tang B; Luo J; Zhang J
Anticancer Drugs; 2024 Jul; 35(6):501-511. PubMed ID: 38478015
[TBL] [Abstract][Full Text] [Related]
16. LINC00313 suppresses autophagy and promotes stemness of nasopharyngeal carcinoma cells through PTBP1/STIM1 axis.
Xu L; Liu S; Yang Y; Shu L; Sun Y
Radiother Oncol; 2024 Jul; 196():110310. PubMed ID: 38677328
[TBL] [Abstract][Full Text] [Related]
17. Extracellular vesicles derived from paclitaxel-sensitive nasopharyngeal carcinoma cells deliver miR-183-5p and impart paclitaxel sensitivity through a mechanism involving P-gp.
Cui X; Chen Y; Zhao L; Ding X
Cell Biol Toxicol; 2023 Dec; 39(6):2953-2970. PubMed ID: 37296288
[TBL] [Abstract][Full Text] [Related]
18. Flotillin-2 promotes cell proliferation via activating the c-Myc/BCAT1 axis by suppressing miR-33b-5p in nasopharyngeal carcinoma.
Liu R; Liu J; Wu P; Yi H; Zhang B; Huang W
Aging (Albany NY); 2021 Mar; 13(6):8078-8094. PubMed ID: 33744853
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ZFAS1 promotes nasopharyngeal carcinoma through activation of Wnt/β-catenin pathway.
Chen X; Li J; Li CL; Lu X
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3423-3429. PubMed ID: 29917194
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol Suppresses Human Nasopharyngeal Carcinoma Cell Growth Via Inhibiting Differentiation Antagonizing Non-Protein Coding RNA (DANCR) Expression.
Zhang J; Jin X; Zhou C; Zhao H; He P; Hao Y; Dong Q
Med Sci Monit; 2020 Jul; 26():e923622. PubMed ID: 32683392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
